In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income on loans | 48.9 | 59.7 | 58.7 | 50.4 | 43.6 | 32.3 | 29.4 | 30.6 |
Interest income on repurchase agreements | 0.5 | 1.8 | 1.1 | 0.5 | 0.2 | 0.1 | 0.1 | |
Total interest income | 55.5 | 66.3 | 64.2 | 53.1 | 45.6 | 33.8 | 30.9 | 32.0 |
Interest expense: |
Interest on deposits | 13.5 | 21.5 | 18.6 | 11.8 | 8.2 | 6.2 | 6.2 | 6.7 |
Interest on borrowings | 1.4 | 1.4 | 1.8 | 1.8 | 1.4 | 0.9 | | |
| 18.5 | 25.6 | 22.3 | 14.2 | 10.0 | 7.5 | 7.5 | 8.5 |
Net interest income | 37.0 | 40.8 | 42.0 | 38.9 | 35.6 | 26.2 | 23.4 | 23.5 |
Provision for loan losses | | | | | 3.0 | -1.0 | 0.6 | 4.2 |
Net interest income after provision for loan losses | 37.0 | 40.8 | 42.0 | 38.9 | 32.6 | 27.3 | 22.8 | 19.3 |
Other non-interest income | 14.3 | 13.4 | 8.8 | 7.7 | 8.7 | 7.7 | 7.1 | 8.9 |
Total non-interest income | 14.3 | 13.4 | 8.8 | 7.7 | 8.7 | 7.7 | 7.1 | 8.9 |
Non-interest expenses | 39.6 | 32.7 | 28.3 | 26.0 | 24.1 | 17.5 | 17.0 | 17.0 |
Pre-tax income before non-recurring items | 15.1 | 21.7 | 19.3 | 19.1 | 17.7 | 17.7 | 14.1 | 10.6 |
Non-recurring items | | | | | | | | -0.5 |
Asset impairment | 6.5 | 0.6 | | 0.9 | 0.5 | 0.3 | 1.2 | |
Pre-tax income | 8.6 | 21.1 | 19.3 | 18.2 | 17.2 | 17.5 | 12.9 | 11.2 |
Income taxes | 3.1 | 4.6 | 5.1 | 7.8 | 6.5 | 6.5 | 4.7 | 4.1 |
Tax rate | 36.3% | 21.9% | 26.2% | 42.8% | 37.7% | 37.3% | 36.3% | 37.1% |
Net income | 5.5 | 16.5 | 14.3 | 10.4 | 10.7 | 11.0 | 8.2 | 7.0 |
Net margin | 10.7% | 30.4% | 28.1% | 22.4% | 25.9% | 31.4% | 27.4% | 24.9% |
|
Basic EPS | $0.85 | $2.44 | $2.13 | $1.57 | $1.71 | $1.94 | $1.84 | $1.45 |
Diluted EPS | $0.84 | $2.43 | $2.10 | $1.55 | $1.67 | $1.90 | $1.79 | $1.43 |
|
Shares outstanding (basic) | 6.5 | 6.7 | 6.7 | 6.6 | 6.3 | 5.7 | 4.5 | 4.8 |
Shares outstanding (diluted) | 6.5 | 6.8 | 6.8 | 6.7 | 6.4 | 5.8 | 4.6 | 4.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |